Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib/Dexamethasone vs Pomalidomide/Dexamethasone in RRMM
NCT03170882Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Aug 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Aug 2017; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03170882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170882.